These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7164013)

  • 1. Repeated occurrence of skin necrosis twice following coumarin intake and subsequently during decrease of vitamin K dependent coagulation factors associated with cholestasis.
    Hofmann V; Frick PG
    Thromb Haemost; 1982 Dec; 48(3):245-6. PubMed ID: 7164013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Problems of oral anticoagulation in an adult with homozygous protein C deficiency and late onset of thrombosis.
    Pescatore P; Horellou HM; Conard J; Piffoux M; Van Dreden P; Ruskone-Fourmestraux A; Samama M
    Thromb Haemost; 1993 Apr; 69(4):311-5. PubMed ID: 8497841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent coumarin-induced skin necrosis in a patient with an acquired functional protein C deficiency.
    Teepe RG; Broekmans AW; Vermeer BJ; Nienhuis AM; Loeliger EA
    Arch Dermatol; 1986 Dec; 122(12):1408-12. PubMed ID: 3789774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Warfarin or acenocoumarol: which is better in the management of oral anticoagulants?
    Barcellona D; Vannini ML; Fenu L; Balestrieri C; Marongiu F
    Thromb Haemost; 1998 Dec; 80(6):899-902. PubMed ID: 9869157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Syncumar-induced necrosis following heparin-induced thrombocytopenia and thrombosis].
    Pósán E; Adi S; Szücs G; Rigó J; Boda Z
    Orv Hetil; 1995 Apr; 136(18):945-8. PubMed ID: 7739854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An unusual anticoagulant complication: total mammary necrosis].
    Födisch HJ; Ortli P
    Wien Klin Wochenschr; 1967 Sep; 79(37):675-7 passim. PubMed ID: 5591370
    [No Abstract]   [Full Text] [Related]  

  • 7. Protein C concentrate in the treatment of warfarin-induced skin necrosis in the protein C deficiency.
    Lewandowski K; Zawilska K
    Thromb Haemost; 1994 Mar; 71(3):395. PubMed ID: 8029804
    [No Abstract]   [Full Text] [Related]  

  • 8. Abrupt versus gradual withdrawal of vitamin K antagonist treatment in patients with venous thromboembolic disease: assessment of hypercoagulability and clinical outcome.
    de Groot MR; Njo TL; van Marwijk Kooy M; Büller HR
    Clin Lab; 2000; 46(11-12):575-81. PubMed ID: 11109505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between maintenance dosages of three vitamin K antagonists: acenocoumarol, warfarin and phenprocoumon.
    van Leeuwen Y; Rosendaal FR; van der Meer FJ
    Thromb Res; 2008; 123(2):225-30. PubMed ID: 18407321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of dietary vitamin K intake in chronic oral anticoagulation: prospective evidence from observational and randomized protocols.
    Franco V; Polanczyk CA; Clausell N; Rohde LE
    Am J Med; 2004 May; 116(10):651-6. PubMed ID: 15121490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Warfarin-induced skin necrosis: report of four cases.
    Horn JR; Danziger LH; Davis RJ
    Am J Hosp Pharm; 1981 Nov; 38(11):1763-8. PubMed ID: 7030072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acenocoumarol decreases tissue factor-dependent coagulation during systemic inflammation in humans.
    Hollenstein U; Homoncik M; Knöbl P; Pernerstorfer T; Graggaber J; Eichler HG; Handler S; Jilma B
    Clin Pharmacol Ther; 2002 May; 71(5):368-74. PubMed ID: 12011822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reinstituting warfarin in patients who develop warfarin skin necrosis.
    Jillella AP; Lutcher CL
    Am J Hematol; 1996 Jun; 52(2):117-9. PubMed ID: 8638632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low dose oral vitamin K to reverse acenocoumarol-induced coagulopathy: a randomized controlled trial.
    Ageno W; Crowther M; Steidl L; Ultori C; Mera V; Dentali F; Squizzato A; Marchesi C; Venco A
    Thromb Haemost; 2002 Jul; 88(1):48-51. PubMed ID: 12152676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition rather than enhancement of hemostatic system activation during initiation of oral anticoagulant treatment.
    Kyrle PA; Brockmeier J; Weltermann A; Eichinger S; Speiser W; Lechner K; Eichler HG
    Thromb Haemost; 1997 Apr; 77(4):685-9. PubMed ID: 9134643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
    D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
    Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Necrosis of the skin after 3 year's treatment with acenocoumarin].
    Cameron AR; van Berkel W; Sixma JJ
    Ned Tijdschr Geneeskd; 1974 Apr; 118(14):505-7. PubMed ID: 4820739
    [No Abstract]   [Full Text] [Related]  

  • 18. Coumarin necrosis induced by renal insufficiency.
    Muniesa C; Marcoval J; Moreno A; Giménez S; Sánchez J; Ferreres JR; Peyrí J
    Br J Dermatol; 2004 Aug; 151(2):502-4. PubMed ID: 15327563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Widespread skin necrosis associated with unfractionated heparin therapy in a patient under chronic coumarin anticoagulation.
    Sanchez-Politta S; Angelillo-Scherrer A; Masouyé I; Borradori L
    J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):327-30. PubMed ID: 16503898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subtherapeutic oral anticoagulant therapy: frequency and risk factors.
    Rombouts EK; Rosendaal FR; van der Meer FJ
    Thromb Haemost; 2009 Mar; 101(3):552-6. PubMed ID: 19277419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.